DAVID ALLISON to Antipsychotic Agents
This is a "connection" page, showing publications DAVID ALLISON has written about Antipsychotic Agents.
Connection Strength
0.848
-
Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: effect modification or regression to the mean? Psychiatry Res. 2009 Dec 30; 170(2-3):172-6.
Score: 0.248
-
Antipsychotic drug-induced weight gain: development of an animal model. Int J Obes (Lond). 2005 Jun; 29(6):607-14.
Score: 0.182
-
The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv. 2003 Apr; 54(4):565-7.
Score: 0.157
-
Effects of risperidone on energy balance in female C57BL/6J mice. Obesity (Silver Spring). 2013 Sep; 21(9):1850-7.
Score: 0.079
-
Risperidone alters food intake, core body temperature, and locomotor activity in mice. Physiol Behav. 2009 Mar 02; 96(3):457-63.
Score: 0.058
-
No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs. Int J Obes (Lond). 2007 Jun; 31(6):1014-22.
Score: 0.051
-
Rimonabant Sanofi-Synth?labo. Curr Opin Investig Drugs. 2004 Apr; 5(4):430-5.
Score: 0.042
-
The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry. 1999 Apr; 60(4):215-20.
Score: 0.030